Pacira BioSciences (PCRX) Receivables (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Receivables of $125.6 million for Q1 2026, up 19.94% year-over-year from $104.7 million in Q1 2025, and up 1.26% quarter-over-quarter from $124.1 million in Q4 2025.
Pacira BioSciences (PCRX) Receivables (2010 - 2026) Analysis & Trends
Pacira BioSciences' Receivables history runs 17 years deep, the most recent figure standing at $125.6 million for Q1 2026.
- In Q1 2026, Receivables rose 19.94% year-over-year to $125.6 million; the TTM figure through Mar 2026 stood at $125.6 million (up 19.94% YoY), while the FY2025 annual figure was $124.1 million, up 9.5% from the prior year.
- Receivables for Q1 2026 stood at $125.6 million, up from $124.1 million in the prior quarter.
- The five-year high for Receivables was $125.6 million in Q1 2026, with the low at $91.1 million in Q2 2022.
- The 5-year median for Receivables is $101.6 million (2024), against an average of $104.4 million.
- The sharpest annual moves came in 2022 and 2023: Receivables jumped 87.04% in 2022, then climbed 1.2% in 2023.
- Pacira BioSciences' Receivables stood at $98.4 million in 2022, then gained by 7.28% to $105.6 million in 2023, then grew by 7.34% to $113.3 million in 2024, then increased by 9.5% to $124.1 million in 2025, then grew by 1.26% to $125.6 million in 2026.
- Business Quant data shows PCRX's Receivables at $125.6 million in Q1 2026, $124.1 million in Q4 2025, and $115.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Pacira BioSciences | 945.90 Mn | 694.87 Mn | 148.24 Mn | 132.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.42 Mn |
| Mar 31, 2026 | 125.64 Mn |
| Dec 31, 2025 | 124.07 Mn |
| Sep 30, 2025 | 115.27 Mn |
| Jun 30, 2025 | 114.37 Mn |
| Mar 31, 2025 | 104.75 Mn |
| Dec 31, 2024 | 113.30 Mn |
| Sep 30, 2024 | 100.65 Mn |
| Jun 30, 2024 | 104.78 Mn |
| Mar 31, 2024 | 101.64 Mn |
| Dec 31, 2023 | 105.56 Mn |
| Sep 30, 2023 | 96.96 Mn |
| Jun 30, 2023 | 99.08 Mn |
| Mar 31, 2023 | 93.21 Mn |
| Dec 31, 2022 | 98.40 Mn |
| Sep 30, 2022 | 93.47 Mn |
| Jun 30, 2022 | 91.11 Mn |
| Mar 31, 2022 | 92.10 Mn |
| Dec 31, 2021 | 96.32 Mn |
| Sep 30, 2021 | 49.98 Mn |